A 24-year-old man from Surrey, Max Vardy, diagnosed with terminal brain cancer, has enrolled in a new medical treatment trial at Queen Mary University of London. The trial aims to identify uniquely activated or repressed genes in his cancerous cells compared to healthy cells, potentially leading to personalized treatment options using new or repurposed drugs.
Max Vardy, from Farnham, was diagnosed with a glioblastoma tumour in June 2024 and, following six weeks of radiotherapy, is currently undergoing chemotherapy.
The 24-year-old said the research gave people hope, "even if not in time for me, then for the future generations that must fight this difficult to cure condition". Silvia Marino, a professor of neuropathology at the university, said brain tumour cells had a different combination of genes that were turned on or off when compared to healthy brain cells.
BRAINTUMOR CANCERRESEARCH GENETICS PERSONALIZEDMEDICINE CLINICALTRIALS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Imperial Beach dad overcomes terminal brain cancer diagnosisPerla was born and raised in Orange County, went to UC Berkeley for her Bachelors, and worked in Bakersfield for her first job as a multimedia journalist.
Read more »
Teenage Cancer Patient Celebrates Being Cancer-Free After Two Years of TreatmentDan Evans, 19, from Newark in Nottinghamshire, rang the 'cancer-free bell' at the teenage cancer ward at Nottingham City Hospital after undergoing a successful stem cell transplant. Mr Evans was diagnosed with stage-four Primary Mediastinal B Cell Lymphoma (PMBCL) in 2022 and faced limited treatment options. His family campaigned for access to a combination of cancer drugs, raising over £50,000 through a fundraiser. After receiving treatment, Mr Evans is now in remission and looking forward to starting his geography degree in September.
Read more »
Moffitt Cancer Center: A Leader in Cancer Research and CareMoffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center dedicated to advancing cancer research and providing exceptional patient care.
Read more »
Neuralink Implants Third Patient, Advancing Brain-Computer Interface ResearchElon Musk announces a third successful Neuralink brain implant, highlighting the progress of this ambitious brain-computer interface technology. While Neuralink continues to make strides, the field of BCI research is rapidly evolving with numerous other companies and research groups pushing the boundaries of what's possible.
Read more »
Epilepsy Patient Samples Offer Unprecedented Insights on Brain 'Brakes' Linked to DisordersResearchers have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer's and Parkinson's diseases and used the discovery to grow the cells in a lab. This finding provides new insights into the mechanisms underlying these neurodegenerative diseases.
Read more »
Brain Surgery Patient's Rehabilitation Covered After News ReportAngel Coronel, a Scripps Health patient recovering from brain surgery, faced a financial dilemma when his insurance, Anthem, went out-of-network with the hospital. A news report by ABC 10News highlighted Coronel's situation, leading to Anthem approving his continued care at Scripps Health.
Read more »